BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2025

  August 12, 2025

   · 

  20 min read
• Press Releases

  Neurogene Reports Second Quarter 2025 Financial Results and Highlights Recent Updates

  August 12, 2025

   · 

  10 min read
• Press Releases

  Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

  August 12, 2025

   · 

  9 min read
• Press Releases

  Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement

  August 12, 2025

   · 

  4 min read
• Press Releases

  Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 11, 2025

  August 12, 2025

   · 

  1 min read
• Press Releases

  Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 11, 2025

  August 12, 2025

   · 

  2 min read
• Press Releases

  Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress

  August 12, 2025

   · 

  14 min read
• Press Releases

  Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2025

  August 12, 2025

   · 

  11 min read
• Press Releases

  Atara Biotherapeutics Announces Second Quarter Financial Results and Operational Progress

  August 12, 2025

   · 

  9 min read
• Press Releases

  Laxxon Medical Announces Successful Product Development Milestone with Novel Oral Modified-Release Formulation of Veru’s Enobosarm, Utilizing Laxxon’s SPID®-Technology

  August 12, 2025

   · 

  3 min read